SPL Mapping FHIR R5 Implementation Guide, published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 0.2.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/fhir-spl/ and changes regularly. See the Directory of published versions
Page standards status: Informative |
{
"resourceType" : "RegulatedAuthorization",
"id" : "Enbrel021Marketing",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalProductMarketing"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: RegulatedAuthorization Enbrel021Marketing</b></p><a name=\"Enbrel021Marketing\"> </a><a name=\"hcEnbrel021Marketing\"> </a><a name=\"Enbrel021Marketing-en-US\"> </a><p><b>identifier</b>: <code>urn:oid:2.16.840.1.113883.3.150</code>/NDA103795</p><p><b>subject</b>: <a href=\"MedicinalProductDefinition-Enbrel021Definition.html\">MedicinalProductDefinition: identifier = http://hl7.org/fhir/sid/ndc#National drug codes#58406-021; route = SUBCUTANEOUS</a></p><p><b>type</b>: <span title=\"Codes:{http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl C73594}\">NDA</span></p><p><b>region</b>: <span title=\"Codes:{urn:iso:std:iso:3166 USA}\">United States of America</span></p></div>"
},
"identifier" : [
{
"system" : "urn:oid:2.16.840.1.113883.3.150",
"value" : "NDA103795"
}
],
"subject" : [
{
🔗 "reference" : "MedicinalProductDefinition/Enbrel021Definition"
}
],
"type" : {
"coding" : [
{
"system" : "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
"code" : "C73594",
"display" : "NDA"
}
]
},
"region" : [
{
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "USA"
}
]
}
]
}